These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 22241939)

  • 1. The Lymphocyte Potassium Channels Kv1.3 and KCa3.1 as Targets for Immunosuppression.
    Lam J; Wulff H
    Drug Dev Res; 2011 Nov; 72(7):573-584. PubMed ID: 22241939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of T cell potassium channels, KV1.3 and KCa3.1, in the inflammatory cascade in ulcerative colitis.
    Hansen LK
    Dan Med J; 2014 Nov; 61(11):B4946. PubMed ID: 25370966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytes.
    Hu L; Pennington M; Jiang Q; Whartenby KA; Calabresi PA
    J Immunol; 2007 Oct; 179(7):4563-70. PubMed ID: 17878353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentially Expressed Potassium Channels Are Associated with Function of Human Effector Memory CD8
    Sim JH; Kim KS; Park H; Kim KJ; Lin H; Kim TJ; Shin HM; Kim G; Lee DS; Park CW; Lee DH; Kang I; Kim SJ; Cho CH; Doh J; Kim HR
    Front Immunol; 2017; 8():859. PubMed ID: 28791017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potassium channels Kv1.3 and KCa3.1 cooperatively and compensatorily regulate antigen-specific memory T cell functions.
    Chiang EY; Li T; Jeet S; Peng I; Zhang J; Lee WP; DeVoss J; Caplazi P; Chen J; Warming S; Hackos DH; Mukund S; Koth CM; Grogan JL
    Nat Commun; 2017 Mar; 8():14644. PubMed ID: 28248292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitis.
    Koch Hansen L; Sevelsted-Møller L; Rabjerg M; Larsen D; Hansen TP; Klinge L; Wulff H; Knudsen T; Kjeldsen J; Köhler R
    J Crohns Colitis; 2014 Nov; 8(11):1378-91. PubMed ID: 24793818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking KV1.3 channels inhibits Th2 lymphocyte function and treats a rat model of asthma.
    Koshy S; Huq R; Tanner MR; Atik MA; Porter PC; Khan FS; Pennington MW; Hanania NA; Corry DB; Beeton C
    J Biol Chem; 2014 May; 289(18):12623-32. PubMed ID: 24644290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ca²⁺-activated K⁺ channel KCa3.1 as a potential new target for the prevention of allograft vasculopathy.
    Chen YJ; Lam J; Gregory CR; Schrepfer S; Wulff H
    PLoS One; 2013; 8(11):e81006. PubMed ID: 24312257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K
    Veytia-Bucheli JI; Jiménez-Vargas JM; Melchy-Pérez EI; Sandoval-Hernández MA; Possani LD; Rosenstein Y
    Cell Commun Signal; 2018 Aug; 16(1):45. PubMed ID: 30107837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potassium channel changes of peripheral blood T-lymphocytes from Kazakh hypertensive patients in Northwest China and the inhibition effect towards potassium channels by telmisartan.
    Zhang Q; Gou F; Zhang Y; He Y; He J; Peng L; Cheng L; Yuan Q; Zhang G; Huang S
    Kardiol Pol; 2016; 74(5):476-488. PubMed ID: 26502942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted inhibition of KCa3.1 channel attenuates airway inflammation and remodeling in allergic asthma.
    Yu ZH; Xu JR; Wang YX; Xu GN; Xu ZP; Yang K; Wu DZ; Cui YY; Chen HZ
    Am J Respir Cell Mol Biol; 2013 Jun; 48(6):685-93. PubMed ID: 23492185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications.
    Wulff H; Kolski-Andreaco A; Sankaranarayanan A; Sabatier JM; Shakkottai V
    Curr Med Chem; 2007; 14(13):1437-57. PubMed ID: 17584055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes.
    Koshy S; Wu D; Hu X; Tajhya RB; Huq R; Khan FS; Pennington MW; Wulff H; Yotnda P; Beeton C
    PLoS One; 2013; 8(10):e76740. PubMed ID: 24146918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis.
    Beeton C; Wulff H; Barbaria J; Clot-Faybesse O; Pennington M; Bernard D; Cahalan MD; Chandy KG; Béraud E
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13942-7. PubMed ID: 11717451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potassium channel KCa3.1 as new therapeutic target for the prevention of obliterative airway disease.
    Hua X; Deuse T; Chen YJ; Wulff H; Stubbendorff M; Köhler R; Miura H; Länger F; Reichenspurner H; Robbins RC; Schrepfer S
    Transplantation; 2013 Jan; 95(2):285-92. PubMed ID: 23325003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kv1.3 channels as a potential target for immunomodulation of CD4+ CD28null T cells in patients with acute coronary syndrome.
    Xu R; Cao M; Wu X; Wang X; Ruan L; Quan X; Lü C; He W; Zhang C
    Clin Immunol; 2012 Feb; 142(2):209-17. PubMed ID: 22169811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Physiological Role of K(+) Channels in the Regulation of T Cell Function].
    Ohya S
    Yakugaku Zasshi; 2016; 136(3):479-83. PubMed ID: 26935090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS.
    Wulff H; Calabresi PA; Allie R; Yun S; Pennington M; Beeton C; Chandy KG
    J Clin Invest; 2003 Jun; 111(11):1703-13. PubMed ID: 12782673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of CCR7(-) effector memory T cell activation by a novel peptide targeting Kv1.3 channel in a rat experimental autoimmune encephalomyelitis model.
    Li Z; Liu WH; Han S; Peng BW; Yin J; Wu YL; He XH; Li WX
    J Biol Chem; 2012 Aug; 287(35):29479-94. PubMed ID: 22761436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting effector memory T-cells with Kv1.3 blockers.
    Wulff H; Pennington M
    Curr Opin Drug Discov Devel; 2007 Jul; 10(4):438-45. PubMed ID: 17659485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.